stella
beta
Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension — Stella
Recruiting
Back to Unresectable Hepatocellular Carcinoma trials
Trial locations
(1 site)
China
Tongji Hospital, Wuhan, Hubei
View full record on ClinicalTrials.gov